NTRA peer analysis
Natera (NTRA) against its competitors: price, today's move, 1-year return and market value side by side.
NTRA and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BLLN BillionToOne | $107.98 | -4.71% | – | – |
| FLGT Fulgent Genetics | $20.62 | -4.89% | -8.68% | $567.37M |
| MYGN Myriad Genetics | $5.91 | -6.93% | -25.66% | $607.38M |
| PSNL Personalis | $15.86 | 0.25% | 66.77% | $1.69B |
| SERA Sera Prognostics | $2.04 | -0.97% | -41.55% | – |
| VCYT Veracyte | $49.56 | -0.90% | 40.28% | $4.02B |
| WGS GeneDx | $65.60 | -5.01% | -50.11% | $2.06B |
| NTRA Natera | $385.60 | -6.93% | 99.57% | $59.72B |
- NTRA's peers: BLLN (BillionToOne), FLGT (Fulgent Genetics), MYGN (Myriad Genetics), PSNL (Personalis), SERA (Sera Prognostics), VCYT (Veracyte), WGS (GeneDx).
Updated 2026-11-02 17:56 UTC